Hopital Foch
Clinical trials sponsored by Hopital Foch, explained in plain language.
-
New hope for pregnancy in women with painful uterine conditions
Disease control Recruiting nowThis study is testing if adding a hormone injection (GnRH agonist) to the standard medication before a frozen embryo transfer can help women with endometriosis or adenomyosis get pregnant. Researchers will compare pregnancy rates between women who receive the extra injection and …
Phase: PHASE2, PHASE3 • Sponsor: Hopital Foch • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Diabetes drug joins fight against deadly brain tumor
Disease control Recruiting nowThis study is testing if adding the common diabetes drug metformin to the standard first treatment (radiation and chemotherapy) can better control a specific type of aggressive brain tumor called glioblastoma. It will include about 64 newly diagnosed patients whose tumors have a …
Phase: PHASE2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
Study aims to sharpen cancer detection with delayed imaging
Diagnosis Recruiting nowThis study is testing whether taking PET scan images 2.5 hours after injection, instead of the standard 1 hour, improves the detection of cancer spread to lymph nodes in patients with muscle-invasive bladder cancer. Researchers will compare the accuracy of the delayed images agai…
Phase: NA • Sponsor: Hopital Foch • Aim: Diagnosis
Last updated Apr 01, 2026 23:26 UTC
-
Zapping ear nerves to ease Women's chronic pain
Symptom relief Recruiting nowThis study is testing a non-invasive device that delivers gentle electrical stimulation to a nerve in the ear. The goal is to see if this stimulation can reduce chronic pelvic pain in women with endometriosis, a condition where tissue similar to the uterine lining grows outside t…
Phase: NA • Sponsor: Hopital Foch • Aim: Symptom relief
Last updated Mar 25, 2026 14:09 UTC
-
Scientists search for clues to stop uterus transplant rejection
Knowledge-focused Recruiting nowThis study aims to understand why the body sometimes rejects a transplanted uterus and to find simple, non-invasive tests to detect rejection early. Researchers will collect samples from 30 women, including transplant recipients, their donors, and a control group. The goal is to …
Phase: NA • Sponsor: Hopital Foch • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC